R. Carruthers

R. Carruthers

Geen lopende functies

Vermogen: 47 444 $ op 31-08-2026

68 jaar
Health Technology
Producer Manufacturing
Commercial Services

Profiel

R.
Michael Carruthers
is currently an Independent Director at OnKure Therapeutics, Inc. since 2024.
Former positions include Chief Financial Officer at Edgewise Therapeutics, Inc. from 2020 to 2025; Chief Financial Officer at Fresh Tracks Therapeutics, Inc. from 2017 to 2020; Chief Financial Officer at ClinOne, Inc. from 2018 to 2020; President and Chief Financial Officer at Alpine Immune Sciences, Inc. in 2017; President, Chief Financial Officer, and Secretary at Nivalis Therapeutics, Inc. in 2017; Chief Financial Officer and Head of Investor Relations at Array BioPharma, Inc. from 2013 to 2015; Independent Director at Elevation Oncology, Inc. from 2021 to 2025; Chief Financial Officer at OnKure, Inc. from 2019 to 2021; Chief Financial Officer at Sievers Instruments, Inc. from 1993 to 1998; Director at Pyxant Labs, Inc. from 2000 to 2012; Treasurer and Controller at Dover Corp.
Waukesha Division from 1989 to 1993; Treasurer and Controller at Waukesha Bearings Corp.; Chief Financial Officer at Vical, Inc.; Senior Auditor at Coopers & Lybrand LLP.
Education includes an MBA from The University of Chicago Booth School of Business and undergraduate studies at the University of Colorado Boulder.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
31-03-2026 795 ( 0% ) 33 207 $ 31-08-2026
0,01%
07-08-2026 3.922 ( 0,01% ) 14 237 $ 31-08-2026

Actieve functies van R. Carruthers

BedrijvenFunctieBegin

Eerdere bekende functies van R. Carruthers

BedrijvenFunctieEinde
EDGEWISE THERAPEUTICS, INC. Financieel Directeur/CFO 10-11-2025
ELEN ONCO Directeur/Bestuurslid 23-07-2025
FRESH TRACKS THERAPEUTICS, INC. Financieel Directeur/CFO 01-10-2020
Financieel Directeur/CFO 01-05-2020
President 01-08-2017
Ervaring van R. Carruthers in detail bekijken

Opleiding van R. Carruthers

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

58

Eerstegraads connecties

16

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit16

Producer Manufacturing

Health Technology

Health Technology

Commercial Services

Health Technology

Commercial Services

Producer Manufacturing

Electronic Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Technology Services

Health Technology

Health Technology

Health Technology

  1. Beurs
  2. Insiders
  3. R. Carruthers
-40 %: uitzonderlijke verlenging
d
:
:
PROFITEER NU